Sexually transmitted diseases (STDs), also known as sexually transmitted infections (STIs), are very common, More than 1 million sexually transmitted infections (STIs) are acquired every day worldwide, the majority of which are asymptomatic. Chlamydia trachomatis (CT), Ureaplasma urealyticum (UU) and Neisseria gonorrhoeae (NG) are common species that cause STDs and urogenital sexually transmitted diseases.
Ureaplasma urealyticum was first described in 1950 by Shepard, who noted minute colonies growing amid larger Mycoplasma colonies in specimens taken from the urethra and urine of men with nongonococcal urethritis. These bacteria were initially called “T-strain” Mycoplasma because of their tiny colony size. Urease production led to the name Ureaplasma urealyticum.
Neisseria gonorrhoeae, also known as gonococcus (singular), or gonococci (plural), is a species of Gram-negative diplococci bacteria isolated by Albert Neisser in 1879. It causes the sexually transmitted genitourinary infection gonorrhea as well as other forms of gonococcal disease including disseminated gonococcemia, septicarthritis, and gonococcal ophthalmia neonatorum.
Chlamydia is a common sexually transmitted disease (STD). It is caused by bacteria called Chlamydia trachomatis. Anyone can get chlamydia. It often doesn't cause symptoms, so people may not know that they have it. Antibiotics can cure it. But if it's not treated, chlamydia can cause serious health problems.
Currently, laboratory tests for Neisseria gonorrhoeae, Chlamydia trachomatis and Ureaplasma urealyticum mainly include bacterial culture methods, immunological tests and nucleic acid tests. Laboratory operators must undergo rigorous professional training in gene amplification or molecular biology methods and have relevant laboratory qualifications.
� Time-saving and labor-saving: One-time sampling can realize the determination of Chlamydia trachomatis (CT), Ureaplasma urealyticum (UU), and Neisseria gonorrhoeae (NG).
� Fast: From sample processing to result out in 90 minutes .
� Simple and fast operation: It only takes 15 minutes to complete the extraction of 96 samples with the Bioer Automatic Nucleic Acid Extractor, which can effectively improve the efficiency of laboratory work.
� Monitoring sampling: Human RNase P gene is used as an internal control, which can not only be used to evaluate sample quality, PCR inhibitory factors, but also prevent false negative results.
� Anti-contamination system: UDG enzyme and dUTP to fully degrade possible contamination and avoid false positive results.
STD detection
Case 1: In the experiment, samples of Neisseria gonorrhoeae with a concentration of 1000 bacteria/mL, samples of Chlamydia trachomatis with a concentration of 1000 copies/mL, and samples of Ureaplasma urealyticum with a concentration of 1000 CCU/mL were selected in the Bioer fluorescent quantitative polymerase chain reaction (PCR) detection system (model: FQD-96A); Bioer real-time fluorescence quantitative PCR analyzer (model: FQD-96C) is used for detection, each sample is repeated 20 times, and the positive detection rate is required to be 100%.
Result: The results showed that the positive detection rate of 1000 bacteria/mL of Neisseria gonorrhoeae, 1000 copies/mL of Chlamydia trachomatis and 1000 CCU/mL of Ureaplasma urealyticum was 100%.
| Cat# | Product Name | Packing size |
| BSJ02S1 |
Neisseria Gonorrhoeae, Chlamydia Trachomatis, Ureaplasma Urealyticum Nucleic Acid Detection Kit (Fluorescent PCR) |
24T |
| BSJ02M1 |
Neisseria Gonorrhoeae, Chlamydia Trachomatis, Ureaplasma Urealyticum Nucleic Acid Detection Kit (Fluorescent PCR) |
48T |
| BSJ02L1 |
Neisseria Gonorrhoeae, Chlamydia Trachomatis, Ureaplasma Urealyticum Nucleic Acid Detection Kit (Fluorescent PCR) |
96T |